<DOC>
	<DOCNO>NCT01867580</DOCNO>
	<brief_summary>The purpose study examine effectiveness V.A.C.Ulta Negative Pressure Wound Therapy System V.A.C . VeraFlo Dressing System wound require operative debridement .</brief_summary>
	<brief_title>A Prospective , Multi-Center Trial Evaluating Effectiveness V.A.C . Ulta Negative Pressure Wound Therapy System With V.A.C . VeraFlo Dressing System Operatively Debrided Wounds</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>The Subject : wound prior inform consent admit inpatient &gt; = 18 year age time consent able provide his/her informed consent willing able return schedule require study visit open wound &gt; = 4cm plane measurement exclude tunnel initial surgical debridement wound appropriate NPWT accord approve indication use participated clinical trial within past 30 day 30 day wind history available wound previously treat The Subject : pregnant determine positive serum urine pregnancy test time screen life expectancy &lt; 12 month healthy enough undergo surgery reason , investigator 's opinion , clinically significant condition would impair participant 's ability comply study procedure , opinion investigator , condition allow subject tolerate therapy ( e.g . painful condition vasculitis ) rheumatoid arthritis bleed disorder coagulopathy wound contain antibiotic cement bead ischemic low extremity wound determine lack detectable pulse extremity anklebrachial pressure index &lt; 0.9 history diabetes , &lt; 0.6 subject nondiabetic know allergy hypersensitivity V.A.C . Therapy dress component include polyurethane polyvinyl alcohol ( drape foam ) , material contain acrylic adhesive ( drape adhesive ) know allergy hyper sensitivity 3M Cavilon No Sting Barrier Film component include Hexamethyldisiloxane , isooctane , acrylate terpolymer , polyphenylmethysiloxane , copolymer know allergy hypersensitivity Prontosan component include polyhexamethylene biguanide ( PHMB ) , undecylenamidopropyl betaine receive NPWT study wound within last 30 day wound contraindicate Prontosan a. presence hyaline cartilage wound wound contraindicate V.A.C . Therapy include : 1. malignancy wind 2. untreated osteomyelitis 3. nonenteric unexplored fistula 4. necrotic tissue eschar remain wound debridement ( NOTE : Once necrotic tissue eschar remove wound bed , subject may include ) 5. unprotected , expose blood vessel , anastomotic site , organ , nerve direct contact foam use intervene layer wind bed foam wound contraindicate V.A.C . VeraFlo Therapy include : 1 . Thoracic abdominal cavity 2 . Unexplored wound may communicate adjacent body cavity wind close initial debridement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>